Phase I trial of BT 061 in volunteers.
Phase of Trial: Phase I
Latest Information Update: 24 Jun 2010
At a glance
- Drugs Tregalizumab (Primary)
- Indications Psoriasis; Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Biotest AG
- 24 Jun 2010 Results reported at 11th Annual Congress of the European League Against Rheumatism (EULAR).
- 24 Jun 2010 New trial record